Renalytix shares surge 50% on unsolicited takeover approach
Shares soar almost 50% on unsolicited approachBoard hoists ?for sale? sign amid strategic reviewDiscussions to raise new equity and debtAn unsolicited takeover approach for kidney diagnostics specialist Renalytix (RENX:AIM) sent its shares soaring 46% higher to 58.5p on Monday, taking year-to-date gains to the best part of 160%.On 9 February, the shares jumped 35% after the US CMS (Centers for Med